S&P 500 5,278.40 +0.45% NASDAQ 16,755.02 +0.67% DOW JONES 38,886.57 +0.32% RUSSELL 2000 2,084.45 +0.15% VIX 13.42 -1.52% GOLD 2,348.30 +0.21% OIL (WTI) 78.62 +0.18% US 10Y 4.28% -0.04%
All articles Labor Market

Ionis Pharmaceuticals is Now Oversold (IONS)

Ionis Pharmaceuticals is Now Oversold (IONS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of Ionis Pharmaceuticals Inc (Symbol: IONS) entered into oversold territory, hitting an RSI reading of 26.3, after changing hands as low as $58.20 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 58.1. A bullish investor could look at IONS’s 26.3 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of IONS shares:

Looking at the chart above, IONS’s low point in its 52 week range is $40.03 per share, with $86.74 as the 52 week high point — that compares with a last trade of $58.25.

Further IONS Research:

Eagle One Intelligence

The edge serious investors read.

Macro shifts, market structure, and the ideas worth tracking — straight to your inbox.

Note. For informational purposes only. Not financial advice. Past performance does not guarantee future results.